This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colque-Navarro, P.
Right arrow Articles by Möllby, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colque-Navarro, P.
Right arrow Articles by Möllby, R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2000, p. 14-20, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Antibody Responses in Patients with Staphylococcal Septicemia against Two Staphylococcus aureus Fibrinogen Binding Proteins: Clumping Factor and an Extracellular Fibrinogen Binding Protein

Patricia Colque-Navarro,1,* Marco Palma,2 Bo Söderquist,3 Jan-Ingmar Flock,2 and Roland Möllby1

Microbiology and Tumorbiology Center, Karolinska Institute, S-171 77 Stockholm,1 Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Karolinska Institute, S-141 86 Huddinge,2 and Department of Infectious Diseases, Örebro Medical Center Hospital, S-701 85 Örebro,3 Sweden

Received 24 March 1999/Returned for modification 28 June 1999/Accepted 27 September 1999

We analyzed the serum antibody responses against two Staphylococcus aureus fibrinogen binding proteins, the cell-bound clumping factor (Clf) and an extracellular fibrinogen binding protein (Efb). The material consisted of 105 consecutive serum samples from 41 patients suffering from S. aureus septicemia and 72 serum samples from healthy individuals. An enzyme-linked immunosorbent assay (ELISA) was developed. Healthy individuals showed variable levels of antibodies against the studied antigens, and cutoff levels (upper 95th percentile) against these antigens were determined. No correlation was seen between serum antibody levels against Clf and Efb. In acute-phase samples 27% of patients showed positive antibody levels against Clf and 10% showed positive levels against Efb, while in convalescent-phase samples 63% (26 of 41) showed a positive serology against Clf and 49% (20 of 41) showed a positive serology against Efb. Antibody levels against Efb were significantly lower in the acute-phase sera than in sera from healthy individuals (P = 0.002). An antibody response against Clf was most frequent in patients suffering from osteitis plus septic arthritis and from endocarditis (80% positive). The antibody response against Efb appeared to develop later in the course of disease. A possible biological effect of measured antibodies was demonstrated with the help of an inhibition ELISA, in which both high-titer and low-titer sera inhibited the binding of bacteria to fibrinogen. In conclusion, we have demonstrated in vivo production of S. aureus fibrinogen binding proteins during deep S. aureus infections and a possible diagnostic and prophylactic role of the corresponding serum antibodies in such infections.


* Corresponding author. Mailing address: Karolinska Institute, MTC, S-171 77 Stockholm, Sweden. Phone: 46 8 728 7155. Fax: 46 8 33 15 47. E-mail: patricia.colque{at}mtc.ki.se.


Clinical and Diagnostic Laboratory Immunology, January 2000, p. 14-20, Vol. 7, No. 1
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Domanski, P. J., Patel, P. R., Bayer, A. S., Zhang, L., Hall, A. E., Syribeys, P. J., Gorovits, E. L., Bryant, D., Vernachio, J. H., Hutchins, J. T., Patti, J. M. (2005). Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus. Infect. Immun. 73: 5229-5232 [Abstract] [Full Text]  
  • Dryla, A., Prustomersky, S., Gelbmann, D., Hanner, M., Bettinger, E., Kocsis, B., Kustos, T., Henics, T., Meinke, A., Nagy, E. (2005). Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients. CVI 12: 387-398 [Abstract] [Full Text]  
  • Teng, F., Kawalec, M., Weinstock, G. M., Hryniewicz, W., Murray, B. E. (2003). An Enterococcus faecium Secreted Antigen, SagA, Exhibits Broad-Spectrum Binding to Extracellular Matrix Proteins and Appears Essential for E. faecium Growth. Infect. Immun. 71: 5033-5041 [Abstract] [Full Text]  
  • Weichhart, T., Horky, M., Sollner, J., Gangl, S., Henics, T., Nagy, E., Meinke, A., von Gabain, A., Fraser, C. M., Gill, S. R., Hafner, M., von Ahsen, U. (2003). Functional Selection of Vaccine Candidate Peptides from Staphylococcus aureus Whole-Genome Expression Libraries In Vitro. Infect. Immun. 71: 4633-4641 [Abstract] [Full Text]  
  • Ellis, M., Serreli, A., Colque-Navarro, P., Hedstrom, U., Chacko, A., Siemkowicz, E., Mollby, R. (2003). Role of staphylococcal enterotoxin A in a fatal case of endocarditis. J Med Microbiol 52: 109-112 [Abstract] [Full Text]  
  • Neth, O., Jack, D. L., Johnson, M., Klein, N. J., Turner, M. W. (2002). Enhancement of Complement Activation and Opsonophagocytosis by Complexes of Mannose-Binding Lectin with Mannose-Binding Lectin-Associated Serine Protease After Binding to Staphylococcus aureus. J. Immunol. 169: 4430-4436 [Abstract] [Full Text]  
  • Moore, P. C. L., Lindsay, J. A. (2001). Genetic Variation among Hospital Isolates of Methicillin-Sensitive Staphylococcus aureus: Evidence for Horizontal Transfer of Virulence Genes. J. Clin. Microbiol. 39: 2760-2767 [Abstract] [Full Text]  
  • Tapper, H., Herwald, H. (2000). Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 96: 2329-2337 [Full Text]  
  • Palma, M., Shannon, O., Quezada, H. C., Berg, A., Flock, J.-I. (2001). Extracellular Fibrinogen-binding Protein, Efb, from Staphylococcus aureus Blocks Platelet Aggregation Due to Its Binding to the alpha -Chain. J. Biol. Chem. 276: 31691-31697 [Abstract] [Full Text]